Higher-potency topical corticosteroids, JAK inhibitors, and tacrolimus 0.1% were deemed the most effective topical anti-inflammatory treatments for atopic dermatitis (AD) following a network meta-analysis published recently in the . PDE-4 inhibitors ranked among the least-effective eczema treatments, along with milder topical corticosteroids and tapinarof 1%.
Novel U.S. vaccines are tested against placebos, despite recent suggestions to the contrary
In contrast to relapsing‐remitting patterns, persistently active disease (PAD) is a disease activity pattern in patients with systemic lupus erythematosus (SLE) that is inadequately studied.…
According to the results of a new study from Japan, the size of lymph nodes on preoperative computed tomography in patients with resectable colon cancer…
Acute severe ulcerative colitis (ASUC) is associated with a significant risk of colectomy and requires timely and effective medical intervention to reduce morbidity and mortality.…
Accreditation must remain independent to protect equity in medicine
Single-arm trial shows steroid-sparing for most patients
Recent developments of interest in cardiovascular medicine
Zasocitinib, a tyrosine kinase 2 (TYK2) inhibitor, holds promise as a new oral treatment for psoriasis, randomized clinical trial data suggest. Results of the multisite…
Their leadership must be grounded in sound public health priorities
